MONDAY
Recursion Pharmaceuticals, Inc. - Class A
SCoRE: 52
LAST PRICE - AT THE CLOSE
RXRX is DOWN -13% since the begininning of the year
RXRX is DOWN -5% BELOW 20 day SMA
RXRX is DOWN -3% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.39
EARNINGS MOMENTUM: YES
0.05% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 79.9% AWAY FROM ALL-TIME HIGHS OF $42.81 |
 |
RXRX IS DOWN -13% SINCE THE BEGINNING OF THE YEAR |
 |
RXRX IS DOWN -6% OVER THE PAST 12 MONTHS |
 |
RXRX IS DOWN -0% OVER THE PAST 1 MONTH |
 |
26% OF ALL RXRX INVESTORS ARE BETTING AGAINST RXRX |
 |
NUM INVESTORS SHORT RXRX HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New premarket high. ... | 06/10 |
 | New premarket low. ... | 06/10 |
 | Trading 2% above VWA... | 06/10 |
 | Crossed below VWAP | 06/10 |
 | Gap reversal, Gap=-0... | 06/10 |
 |
RXRX moved down 0.8 in the previous minute |
 |
RXRX is up 0.23 over the last hour |
 |
RXRX is up 4.7% over the last 5 days |
 |
RXRX is 0 above its 8 day SMA |
| $8.33 |   DAY |
$8.68 |
| $8.42 |  PREVIOUS DAY |
$8.94 |
| $8.27 | WEEK |
$9.22 |
| $8.22 | MONTH |
$10.66 |
| $4.97 | YEAR |
$16.75 |
RXRX is mentioned N/A less than normal on 
RXRX is mentioned N/A times in an average day on 
